253 related articles for article (PubMed ID: 30343454)
1. Machine learning for diagnostic ultrasound of triple-negative breast cancer.
Wu T; Sultan LR; Tian J; Cary TW; Sehgal CM
Breast Cancer Res Treat; 2019 Jan; 173(2):365-373. PubMed ID: 30343454
[TBL] [Abstract][Full Text] [Related]
2. Machine learning analysis of breast ultrasound to classify triple negative and HER2+ breast cancer subtypes.
Ferre R; Elst J; Senthilnathan S; Lagree A; Tabbarah S; Lu FI; Sadeghi-Naini A; Tran WT; Curpen B
Breast Dis; 2023; 42(1):59-66. PubMed ID: 36911927
[TBL] [Abstract][Full Text] [Related]
3. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
[TBL] [Abstract][Full Text] [Related]
4. Automatic identification of triple negative breast cancer in ultrasonography using a deep convolutional neural network.
Ye H; Hang J; Zhang M; Chen X; Ye X; Chen J; Zhang W; Xu D; Zhang D
Sci Rep; 2021 Oct; 11(1):20474. PubMed ID: 34650065
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Ultrasound Elastography and Color Doppler Ultrasonography for Distinguishing Small Triple-Negative Breast Cancer From Fibroadenoma.
Yeo SH; Kim GR; Lee SH; Moon WK
J Ultrasound Med; 2018 Sep; 37(9):2135-2146. PubMed ID: 29424448
[TBL] [Abstract][Full Text] [Related]
6. Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers.
Boisserie-Lacroix M; Macgrogan G; Debled M; Ferron S; Asad-Syed M; McKelvie-Sebileau P; Mathoulin-Pélissier S; Brouste V; Hurtevent-Labrot G
Oncologist; 2013; 18(7):802-11. PubMed ID: 23821326
[TBL] [Abstract][Full Text] [Related]
7. Color Doppler Ultrasound Improves Machine Learning Diagnosis of Breast Cancer.
Moustafa AF; Cary TW; Sultan LR; Schultz SM; Conant EF; Venkatesh SS; Sehgal CM
Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32854253
[TBL] [Abstract][Full Text] [Related]
8. Machine learning to improve breast cancer diagnosis by multimodal ultrasound.
Sultan LR; Schultz SM; Cary TW; Sehgal CM
IEEE Int Ultrason Symp; 2018 Oct; 2018():. PubMed ID: 34295453
[TBL] [Abstract][Full Text] [Related]
9. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.
Xie T; Zhao Q; Fu C; Bai Q; Zhou X; Li L; Grimm R; Liu L; Gu Y; Peng W
Eur Radiol; 2019 May; 29(5):2535-2544. PubMed ID: 30402704
[TBL] [Abstract][Full Text] [Related]
11. Suspicious breast lesions: assessment of 3D Doppler US indexes for classification in a test population and fourfold cross-validation scheme.
LeCarpentier GL; Roubidoux MA; Fowlkes JB; Krücker JF; Hunt KA; Paramagul C; Johnson TD; Thorson NJ; Engle KD; Carson PL
Radiology; 2008 Nov; 249(2):463-70. PubMed ID: 18936310
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
13. Computer-Aided Diagnosis for Breast Ultrasound Using Computerized BI-RADS Features and Machine Learning Methods.
Shan J; Alam SK; Garra B; Zhang Y; Ahmed T
Ultrasound Med Biol; 2016 Apr; 42(4):980-8. PubMed ID: 26806441
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic features of triple-negative breast cancer: a comparison with other breast cancer subtypes.
Yang Q; Liu HY; Liu D; Song YQ
Asian Pac J Cancer Prev; 2015; 16(8):3229-32. PubMed ID: 25921124
[TBL] [Abstract][Full Text] [Related]
15. Going beyond a First Reader: A Machine Learning Methodology for Optimizing Cost and Performance in Breast Ultrasound Diagnosis.
Venkatesh SS; Levenback BJ; Sultan LR; Bouzghar G; Sehgal CM
Ultrasound Med Biol; 2015 Dec; 41(12):3148-62. PubMed ID: 26354997
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Ultrasonic Features of Triple-Negative Breast Cancers: A Comparison with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancers.
Wang D; Zhu K; Tian J; Li Z; Du G; Guo Q; Wu T; Li J
Ultrasound Med Biol; 2018 May; 44(5):1124-1132. PubMed ID: 29482888
[TBL] [Abstract][Full Text] [Related]
17. Predicting the molecular subtype of breast cancer and identifying interpretable imaging features using machine learning algorithms.
Ma M; Liu R; Wen C; Xu W; Xu Z; Wang S; Wu J; Pan D; Zheng B; Qin G; Chen W
Eur Radiol; 2022 Mar; 32(3):1652-1662. PubMed ID: 34647174
[TBL] [Abstract][Full Text] [Related]
18. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.
Agner SC; Rosen MA; Englander S; Tomaszewski JE; Feldman MD; Zhang P; Mies C; Schnall MD; Madabhushi A
Radiology; 2014 Jul; 272(1):91-9. PubMed ID: 24620909
[TBL] [Abstract][Full Text] [Related]
19. Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis.
Li JW; Cao YC; Zhao ZJ; Shi ZT; Duan XQ; Chang C; Chen JG
Eur Radiol; 2022 Mar; 32(3):1590-1600. PubMed ID: 34519862
[TBL] [Abstract][Full Text] [Related]
20. Radiomics Analysis on Ultrasound for Prediction of Biologic Behavior in Breast Invasive Ductal Carcinoma.
Guo Y; Hu Y; Qiao M; Wang Y; Yu J; Li J; Chang C
Clin Breast Cancer; 2018 Jun; 18(3):e335-e344. PubMed ID: 28890183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
